天津医药

天津医药 ›› 2015, Vol. 43 ›› Issue (8): 892-895.doi: 10.11958/j.issn.0253-9896.2015.08.017

• 临床研究 • 上一篇    下一篇

钙网织蛋白促进新生血管形成在类风湿关节炎发病机制中的作用

赵海勇，丁红梅，刘建华，邢冬红，刘弘毅，魏蔚，郑芳   

  1. 1河北省唐山市工人医院骨外一科（邮编063000）；2河北省唐山市第二医院检验科，3手三科；4天津医科大学医学检验学院；5 天津医科大学总医院风湿免疫科
  • 收稿日期:2015-04-03 修回日期:2015-04-28 出版日期:2015-08-15 发布日期:2015-08-15
  • 通讯作者: 郑芳 E-mail:dingding3725071@sina.com
  • 基金资助:
    教育部博士点基金资助项目;天津市应用基础与前沿技术研究计划面上项目

Increased expression of calreticulin promotes angiogenesis involved in the pathogenesis of rheumatoid arthritis

ZHAO Haiyong, DING Hongmei, LIU Jianhua, XING Donghong, LIU Hongyi, WEI wei, ZHENG Fang   

  1. 1 Department of Orthopedics, Tangshan Worker′s Hospital, Tangshan 063000, China; 2 Department of Clinical Laboratory, The Second Hospital of Tangshan; 3 Department of Hand Surgery, The Second Hospital of Tangshan; 4 School of Laboratory Medicine, Tianjin Medical University; 5 Department of Rheumatology, General Hospital of Tianjin Medical University
  • Received:2015-04-03 Revised:2015-04-28 Published:2015-08-15 Online:2015-08-15
  • Supported by:
    教育部博士点基金资助项目（20101202110008）；天津市应用基础与前沿技术研究计划面上项目（14JCYBJC25600）

PDF (PC)

3775

摘要： 目的探讨钙网织蛋白（CRT）促进新生血管形成在类风湿关节炎（RA）发病机制中的作用。方法采用酶联免疫吸附试验（ELISA）法检测活动期RA 患者、骨性关节炎（OA）患者和健康对照组（HC）血清以及RA 和OA 患者关节滑膜液中CRT 的含量。采用免疫组织化学（IHC）法检测CRT 在RA 和OA 患者关节滑膜组织中的表达。应用人脐静脉内皮细胞（HUVECs）体外模型，分别采用MTT 实验、细胞划痕实验及构建体外血管生成的三维模型检测 CRT 在HUVECs 增殖、迁移及管腔形成中的作用。结果RA 组血清中CRT 含量（[ 6.4±3.1）μg/L]明显高于OA 组（[ 3.7±0.9）μg/L]及HC 组（[ 3.4±1.0）μg/L]；RA 组滑膜液中CRT 含量（[ 6.9±3.4）μg/L]明显高于OA 组（[ 3.9±0.7）μg/L]，差异有统计学意义（P < 0.01）。CRT 在RA 滑膜组织中高表达，主要位于滑膜衬里层和衬里下层的血管内皮细胞及血管周围、炎性细胞内外等，而OA 滑膜组织中CRT 仅见极少量的表达。MTT 实验、细胞划痕实验及体外血管生成三维模型检测结果显示，CRT 具有明显促进HUVECs 增殖、迁移及管腔形成的作用。结论CRT 在RA 患者血清、滑膜液及滑膜组织中表达均升高，CRT 可能通过促进新生血管形成参与RA 滑膜炎和血管翳形成的发病机制。

关键词: 关节炎, 类风湿, 新生血管形成, 钙网织蛋白

Abstract: Objective Calreticulin（CRT）is a multifunctional protein of endoplasmic reticulum implicated in the pathogenesis of rheumatoid arthritis（RA）. The present study was undertaken to determine whether CRT was involved in an⁃ giogenesis events in RA. Methods Serum CRT levels were measured by enzyme-linked immnuosorbent assay（ELISA）in 106 patients with established RA, 75 osteoarthritis（OA）and 80 healthy controls（HC）. CRT levels in synovial fluid were al⁃ so measured in 25 RA and 22 OA patients. The expression of CRT in synovial tissue was examined by immunohistology. In order to investigate the role of CRT on angiogenesis, human umbilical vein endothelial cells（HUVECs）were isolated and cultured for in vitro experiments. The proliferation, migration and tube formation of HUVECs following CRT stimulation were examined in vitro by MTT assay, scratch wound healing assay and tube formation assay. Results Our results showed a sig⁃ nificantly higher concentration of CRT in serum [(6.4±3.1) μg/L] of RA patients compared to that of OA [(3.7±0.9) μg/L, P < 0.01] and HC [(3.4±1.0) μg/L, P < 0.01]; and significantly higher CRT in synovial fluid [(6.9±3.4) μg/L] of RA vs OA [(3.9± 0.7) μg/L, P < 0.01]. Increased CRT expression predominantly localized to vascular endothelial cells, inflammatory cells and perivascular areas in both the lining and sublining layers of RA synovial tissue. Furthermore, CRT significantly promoted the proliferation, migration and tube formation of HUVECs, as showed by MTT assay, scratch wound healing assay and tube for⁃ mation assay. Conclusion These findings suggested that CRT may be involved in synovitis and pannus formation events via promoting angiogenesis in RA.

Key words: arthritis, rheumatoid, angiogenesis, calreticulin